The most effective anti-aging therapy to maintain youthful cellular energy metabolism by taking Acetyl-L-Carnitine

Aging occurs when the energy producing components of the cell deteriorate, resulting in reduced cellular metabolic activity, the accumulation of cellular debris, and the eventual death of the cell.

The most effective antiaging therapy to maintain youthful cellular energy metabolism is the amino acid L-carnitine, which functions via several mechanisms to protect cells from the effects of aging.

Acetyl-L-carnitine is the acetylated ester of the amino acid L-carnitine. Acetyl-L-carnitine is absorbed into the bloodstream more efficiently than L-carnitine and, more importantly, acetyl-L-carnitine passes more effectively through cell membranes, and is utilized more efficiently in the mitochondria of the cell.

Acetyl-L-carnitine is sold as a drug in Europe at outrageously high prices. Europeans often use acetyl-L-carnitine to treat age related neurological dysfunction and/or congestive heart failure. Published studies indicate that long-term cognitive enhancing benefits can be attained by taking acetyl-L-carnitine for only several months.

Suggested use of this product is:
Acetyl-L-carnitine should be taken on an empty stomach with water. If you are using the average of 2 per day, take one in the morning 30-45 minutes before breakfast, and one 30-45 minutes before lunch. If you are using 4 per day and you do not have Alzheimer's or any other type of serious disorder take 2 capsules 30-45 minutes before breakfast and 2 capsules 30-45 minutes before lunch. If you are using this for Alzheimer's or another serious disorder take 1 capsule on an empty stomach (30-45 minutes before meals or 2-3 hours after meals) every 4 hours. If your physician has made a recommendation please follow his/her instructions.

 

Ingredient Quantity Measure RDA * Acetyl L-Carnitine - Per Capsule  500  mg  Not Established  Other Ingredients: White Rice, Magnesium Stearate, Gelatin, Water

* RDA means the Recommended Daily Allowance established by the U.S. Food and Drug Administration. This is the minimum daily amounts of specific essential nutrients necessary for healthy adults 18 year of age. Requirements increase with age and the RDA may be insufficient for older adults or those with poor health

Ward Dean, MD explains the benefits of taking Acetyl-L-Carnitine:

One of the most common characteristics of aging is a loss of energy. I am reminded of this dry scientific fact every day as I try to keep up with my two sons- seemingly perpetual motion dynamos aged 9 and 10. It is widely believed that one cause of this age-related decline in energy metabolism is due to loss of mitochondrial function. The mitochondria, remember, are the cellular "powerhouses.". In fact, it has been hypothesized that aging could be due entirely to mitochondrial dysfunction (Harman, 1972; Miguel, et al, 1980). Mitochondrial produce metabolic energy by a process known as oxidative phophorylation, which results in the production of adenosine triphosphate (ATP), the key energy source in the body. Mitochondrial membranes are considered by many scientists to be the likely subcellular site of the age-related decline in mitochondrial function. Many mitochondrial tasks are believed to depend on the lipid composition and content, as well as lipid-protein interactions of the mitochondrial membrane. It is believed that the decreased energy production with aging is due to alteration of the lipid composition and content of mitochondrial membranes. These alterations and methods of reversing them have not, until recently, been clearly identified.

Cytochrome C oxidase, is an enzyme complex in mitochondria which is a vital component of cellular energy processes and is responsible for virtually all oxygen consumption in mammals. A team of Italian scientists (Paradies, et al, 1994) recently found that the maximal activity of cytochrome C oxidase was markedly reduced (about 30%) in mitochondria from aged rats, compared to mitochondria from young rats. This reduction in activity of this critical enzyme appears to be the one explanation for the reduction in formation of ATP (and reduced energy) with age. After treating aged rats with Acetyl-L-Carnitine (ALC) the scientists were gratified to find that the activity of this enzyme system restored to the activity level of young rats.

These same Italian scientist found that the activity of a enzyme- adenine nucleotide translocase (ANT) also decreases with age. ANT is a carrier protein translocates (exchanges) ATP for ADP across the inner mitochondrial membrane from inside the mitochondrion, to the cytosol (outside of the mitochondrion, but inside the cell. This decreased activity of ANT results in reduced ATP available for cellular energy production. Again, after treatment of aged rats with acetyl-L-carnitine, the scientists found that ADP transport of rat heart mitochondria was restored to the level of young rats .

Cardiolipin (diphosphatidyl glycerol) is a phospholipid that is bio sized and concentrated almost exclusively in the inner mitochondrial membrane.

When the Italians analyzed and compared the phospholipid content of the mitochondrial membranes of young and old rats, they found changes in the relative concentrations of (1) phosphatidyl ethanolamine, (2) phosphatidyl inositol. (3) phosphatidyl serine, or (4) phosphatidyl choline. However, they did find a 30% drop in cardiolipin concentrations. Significantly, maximal activity of cytochrome C oxidase appears to depend upon cardiolipin levels. The scientists again found that treatment of aged rats with acetyl-L-carnitine restored cardiolipin in mitochondrial membranes to youthful levels. They also found that restoration of mitochondrial membrane cardiolipin content to youthful levels was associated with parallel restoration of the functional activity of the mitochondria themselves.

They drew the conclusion that restoration of the juvenile lipid microenvironment (i.e., restoration of inner mitochondrial membrane cardolipin levels) by acetyl-L-carnitine is the most obvious explanation of acetyl-L-carnitine's rejuvenating effect on cytochrome C oxidase activity as well.

They concluded that restoration of these functions to youthful levels should allow more efficient oxidative phophorylation, thereby improving performance in aged animals.

The doses administered to the rats in these studies were massive- 300mg/ Kg of bodyweight! In human terms, this would equate directly to 21 grams! Does this mean that in order to obtain the same mitochondrial rejuvenating benefits the rats gained, we would have to consume 21 grams of acetyl-L-carnitine each day? I don't believe so. First, because of the differences in metabolism, animal doses are seldom directly proportional to bio-equivalent human doses. Second, since acetyl-L-carnitine is well documented to be effective in many conditions, including: (1) treating Alzheimer's and Parkinson's disease; (2) enhancing cerebro- and cardio-vascular blood flow; (3) alleviating depression; (4) improving memory and mental performance in normal humans and those suffering from Aging Associated Memory Impairment (AAMI): (5) improving immune function and (6) resolving lipofuscin deposits in humans ("aging spots"), (Dean, et al. 1993)- and all these effects occurred using doses ranging from 1,000mg to 3.000mg daily- it is likely that one to three grams daily will result in enhanced mitochondrial function in humans.

1. Dean W, Morgenthaler J, Fowkes SW, Smart Drugs II, The Next Generation. Vol. 2 in the Smart Drug Series. Smart Publications, Petaluma, 1993.

2. Harman D. The biological clock, the mitochondria? J. Am. Geriatr. Soc.. 20:145-147.

3. Miquel J. Economos AC, Fleming J, Johnson JE, Jr. Mitochondrial role in cell aging. Exp Gerontol. 1980, 15: 575-591.

4. Murray RK, Granner DK. Mayes PA,, Rodwell VW, Harper's Biochemistry edition, 1988, Appleton & Lange, New York.

5. Paradies G, Ruggiero FM, Petrosillo MN. et al. The effect of aging and acetyl-L-carnitine on the function and on the lipid composition of rat heart mitochondria. In: Pharmacology of Aging Processes- Methods of Assessment and Potential Interventions, Annals of the New York Academy of Sciences, Volume 71 Zs.-Nagy I, Harman D, and Kitani K (Eds), New York, 1994, 233-243.